104 related articles for article (PubMed ID: 38747153)
1. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
[TBL] [Abstract][Full Text] [Related]
2. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
[TBL] [Abstract][Full Text] [Related]
3. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
4. Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study.
Lin WY; Liang FW; Lu TH
PLoS One; 2015; 10(5):e0126965. PubMed ID: 25993556
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
[TBL] [Abstract][Full Text] [Related]
6. Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD).
Yap SA; Finelli A; Urbach DR; Tomlinson GA; Alibhai SM
BJU Int; 2015 Jun; 115(6):897-906. PubMed ID: 25065448
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
Ishihara H; Ikeda T; Fukuda H; Yoshida K; Kobayashi H; Iizuka J; Nagashima Y; Kondo T; Takagi T
Int J Urol; 2024 Jan; 31(1):73-81. PubMed ID: 37798866
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
Talenfeld AD; Gennarelli RL; Elkin EB; Atoria CL; Durack JC; Huang WC; Kwan SW
Ann Intern Med; 2018 Jul; 169(2):69-77. PubMed ID: 29946703
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
[TBL] [Abstract][Full Text] [Related]
11. End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline.
Capitanio U; Larcher A; Terrone C; Antonelli A; Volpe A; Fiori C; Furlan M; Dehò F; Minervini A; Serni S; Porpiglia F; Trevisani F; Salonia A; Carini M; Simeone C; Montorsi F; Bertini R
Eur Urol; 2016 Oct; 70(4):558-561. PubMed ID: 27021797
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and Management Considerations in Patients on Dialysis Undergoing Laparoscopic Radical Nephrectomy for Renal-Cell Carcinoma.
Keehn A; Maiman R; Agalliu I; Taylor J; Ghavamian R
J Endourol; 2015 Jun; 29(6):691-5. PubMed ID: 25423552
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis.
Chen K; Huang HH; Aydin H; Tan YH; Lau WK; Cheng CW; Yuen JS
Scand J Urol; 2015 Jun; 49(3):200-4. PubMed ID: 25783025
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma as a cause of end-stage renal disease in the United States: patient characteristics and survival.
Stiles KP; Moffatt MJ; Agodoa LY; Swanson SJ; Abbott KC
Kidney Int; 2003 Jul; 64(1):247-53. PubMed ID: 12787416
[TBL] [Abstract][Full Text] [Related]
15. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
18. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
19. [The clinicopathological characteristics in renal cell carcinoma with end-stage renal disease].
Maru N; Iwamura M; Ishii J; Minei S; Saito T; Yoshida K; Baba S
Nihon Hinyokika Gakkai Zasshi; 2003 Mar; 94(3):434-8. PubMed ID: 12710078
[TBL] [Abstract][Full Text] [Related]
20. Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.
Larcher A; Capitanio U; Terrone C; Volpe A; De Angelis P; Dehó F; Fossati N; Dell'Oglio P; Antonelli A; Furlan M; Simeone C; Serni S; Carini M; Minervini A; Fiori C; Porpiglia F; Briganti A; Montorsi F; Bertini R
J Urol; 2016 Oct; 196(4):1008-13. PubMed ID: 27235789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]